Insider · CIK 0001714982
Curtis Gale Oltmans
Files at FULC (Fulcrum Therapeutics, Inc.). First filing Dec 17, 2025, latest Dec 17, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FULC: Fulcrum Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 19Weak | Fulcrum Therapeutics, Inc. | $45k 3,452 shares | -25% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | FULC Fulcrum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +170,000 | $0.00 | $0 | 170,000 | Feb 4, 2026 |
| Dec 15, 2025 | FULC Fulcrum Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,452 | $12.92 | $45k | 10,252 | Dec 17, 2025 |
| Jan 24, 2025 | FULC Fulcrum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +225,000 | $0.00 | $0 | 225,000 | Jan 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.